Global Dermal Filler and Botolinum Toxin Supply, Demand and Key Producers, 2023-2029

Page: 105

Published Date: 22 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

This report studies the global Dermal Filler and Botolinum Toxin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dermal Filler and Botolinum Toxin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dermal Filler and Botolinum Toxin that contribute to its increasing demand across many markets.

The global Dermal Filler and Botolinum Toxin market size is expected to reach $ 29760 million by 2029, rising at a market growth of 13.3% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Dermal Filler and Botolinum Toxin total production and demand, 2018-2029, (K MT)
Global Dermal Filler and Botolinum Toxin total production value, 2018-2029, (USD Million)
Global Dermal Filler and Botolinum Toxin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Dermal Filler and Botolinum Toxin consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Dermal Filler and Botolinum Toxin domestic production, consumption, key domestic manufacturers and share
Global Dermal Filler and Botolinum Toxin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Dermal Filler and Botolinum Toxin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Dermal Filler and Botolinum Toxin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT)
This reports profiles key players in the global Dermal Filler and Botolinum Toxin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, Anika Therapeutics, Suneva Medical, Contura, HUGEL, Grex Pharma and Daewoong Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dermal Filler and Botolinum Toxin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Dermal Filler and Botolinum Toxin Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Dermal Filler and Botolinum Toxin Market, Segmentation by Type
    Hyaluronic Acid Based Fillers
    Non-Hyaluronic Acid Based Fillers
    Botulinum Toxin

Global Dermal Filler and Botolinum Toxin Market, Segmentation by Application
    Aesthetic Restoration
    Wrinkle Reduction

Companies Profiled:
    Allergan
    Galderma
    Merz Pharma GmbH & Co. KGaA
    Anika Therapeutics
    Suneva Medical
    Contura
    HUGEL
    Grex Pharma
    Daewoong Pharmaceuticals
    Medy-Tox
    TEOXANE Laboratories
    SciVision Biotech

Key Questions Answered
1. How big is the global Dermal Filler and Botolinum Toxin market?
2. What is the demand of the global Dermal Filler and Botolinum Toxin market?
3. What is the year over year growth of the global Dermal Filler and Botolinum Toxin market?
4. What is the production and production value of the global Dermal Filler and Botolinum Toxin market?
5. Who are the key producers in the global Dermal Filler and Botolinum Toxin market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Dermal Filler and Botolinum Toxin Introduction
    1.2 World Dermal Filler and Botolinum Toxin Supply & Forecast
        1.2.1 World Dermal Filler and Botolinum Toxin Production Value (2018 & 2022 & 2029)
        1.2.2 World Dermal Filler and Botolinum Toxin Production (2018-2029)
        1.2.3 World Dermal Filler and Botolinum Toxin Pricing Trends (2018-2029)
    1.3 World Dermal Filler and Botolinum Toxin Production by Region (Based on Production Site)
        1.3.1 World Dermal Filler and Botolinum Toxin Production Value by Region (2018-2029)
        1.3.2 World Dermal Filler and Botolinum Toxin Production by Region (2018-2029)
        1.3.3 World Dermal Filler and Botolinum Toxin Average Price by Region (2018-2029)
        1.3.4 North America Dermal Filler and Botolinum Toxin Production (2018-2029)
        1.3.5 Europe Dermal Filler and Botolinum Toxin Production (2018-2029)
        1.3.6 China Dermal Filler and Botolinum Toxin Production (2018-2029)
        1.3.7 Japan Dermal Filler and Botolinum Toxin Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Dermal Filler and Botolinum Toxin Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Dermal Filler and Botolinum Toxin Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Dermal Filler and Botolinum Toxin Demand (2018-2029)
    2.2 World Dermal Filler and Botolinum Toxin Consumption by Region
        2.2.1 World Dermal Filler and Botolinum Toxin Consumption by Region (2018-2023)
        2.2.2 World Dermal Filler and Botolinum Toxin Consumption Forecast by Region (2024-2029)
    2.3 United States Dermal Filler and Botolinum Toxin Consumption (2018-2029)
    2.4 China Dermal Filler and Botolinum Toxin Consumption (2018-2029)
    2.5 Europe Dermal Filler and Botolinum Toxin Consumption (2018-2029)
    2.6 Japan Dermal Filler and Botolinum Toxin Consumption (2018-2029)
    2.7 South Korea Dermal Filler and Botolinum Toxin Consumption (2018-2029)
    2.8 ASEAN Dermal Filler and Botolinum Toxin Consumption (2018-2029)
    2.9 India Dermal Filler and Botolinum Toxin Consumption (2018-2029)

3 World Dermal Filler and Botolinum Toxin Manufacturers Competitive Analysis
    3.1 World Dermal Filler and Botolinum Toxin Production Value by Manufacturer (2018-2023)
    3.2 World Dermal Filler and Botolinum Toxin Production by Manufacturer (2018-2023)
    3.3 World Dermal Filler and Botolinum Toxin Average Price by Manufacturer (2018-2023)
    3.4 Dermal Filler and Botolinum Toxin Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Dermal Filler and Botolinum Toxin Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Dermal Filler and Botolinum Toxin in 2022
        3.5.3 Global Concentration Ratios (CR8) for Dermal Filler and Botolinum Toxin in 2022
    3.6 Dermal Filler and Botolinum Toxin Market: Overall Company Footprint Analysis
        3.6.1 Dermal Filler and Botolinum Toxin Market: Region Footprint
        3.6.2 Dermal Filler and Botolinum Toxin Market: Company Product Type Footprint
        3.6.3 Dermal Filler and Botolinum Toxin Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Dermal Filler and Botolinum Toxin Production Value Comparison
        4.1.1 United States VS China: Dermal Filler and Botolinum Toxin Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Dermal Filler and Botolinum Toxin Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Dermal Filler and Botolinum Toxin Production Comparison
        4.2.1 United States VS China: Dermal Filler and Botolinum Toxin Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Dermal Filler and Botolinum Toxin Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Dermal Filler and Botolinum Toxin Consumption Comparison
        4.3.1 United States VS China: Dermal Filler and Botolinum Toxin Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Dermal Filler and Botolinum Toxin Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Dermal Filler and Botolinum Toxin Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Dermal Filler and Botolinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Dermal Filler and Botolinum Toxin Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Dermal Filler and Botolinum Toxin Production (2018-2023)
    4.5 China Based Dermal Filler and Botolinum Toxin Manufacturers and Market Share
        4.5.1 China Based Dermal Filler and Botolinum Toxin Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Dermal Filler and Botolinum Toxin Production Value (2018-2023)
        4.5.3 China Based Manufacturers Dermal Filler and Botolinum Toxin Production (2018-2023)
    4.6 Rest of World Based Dermal Filler and Botolinum Toxin Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Dermal Filler and Botolinum Toxin Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production (2018-2023)

5 Market Analysis by Type
    5.1 World Dermal Filler and Botolinum Toxin Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Hyaluronic Acid Based Fillers
        5.2.2 Non-Hyaluronic Acid Based Fillers
        5.2.3 Botulinum Toxin
    5.3 Market Segment by Type
        5.3.1 World Dermal Filler and Botolinum Toxin Production by Type (2018-2029)
        5.3.2 World Dermal Filler and Botolinum Toxin Production Value by Type (2018-2029)
        5.3.3 World Dermal Filler and Botolinum Toxin Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Dermal Filler and Botolinum Toxin Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Aesthetic Restoration
        6.2.2 Wrinkle Reduction
    6.3 Market Segment by Application
        6.3.1 World Dermal Filler and Botolinum Toxin Production by Application (2018-2029)
        6.3.2 World Dermal Filler and Botolinum Toxin Production Value by Application (2018-2029)
        6.3.3 World Dermal Filler and Botolinum Toxin Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Allergan
        7.1.1 Allergan Details
        7.1.2 Allergan Major Business
        7.1.3 Allergan Dermal Filler and Botolinum Toxin Product and Services
        7.1.4 Allergan Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Allergan Recent Developments/Updates
        7.1.6 Allergan Competitive Strengths & Weaknesses
    7.2 Galderma
        7.2.1 Galderma Details
        7.2.2 Galderma Major Business
        7.2.3 Galderma Dermal Filler and Botolinum Toxin Product and Services
        7.2.4 Galderma Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Galderma Recent Developments/Updates
        7.2.6 Galderma Competitive Strengths & Weaknesses
    7.3 Merz Pharma GmbH & Co. KGaA
        7.3.1 Merz Pharma GmbH & Co. KGaA Details
        7.3.2 Merz Pharma GmbH & Co. KGaA Major Business
        7.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product and Services
        7.3.4 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Merz Pharma GmbH & Co. KGaA Recent Developments/Updates
        7.3.6 Merz Pharma GmbH & Co. KGaA Competitive Strengths & Weaknesses
    7.4 Anika Therapeutics
        7.4.1 Anika Therapeutics Details
        7.4.2 Anika Therapeutics Major Business
        7.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Product and Services
        7.4.4 Anika Therapeutics Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Anika Therapeutics Recent Developments/Updates
        7.4.6 Anika Therapeutics Competitive Strengths & Weaknesses
    7.5 Suneva Medical
        7.5.1 Suneva Medical Details
        7.5.2 Suneva Medical Major Business
        7.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Product and Services
        7.5.4 Suneva Medical Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Suneva Medical Recent Developments/Updates
        7.5.6 Suneva Medical Competitive Strengths & Weaknesses
    7.6 Contura
        7.6.1 Contura Details
        7.6.2 Contura Major Business
        7.6.3 Contura Dermal Filler and Botolinum Toxin Product and Services
        7.6.4 Contura Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Contura Recent Developments/Updates
        7.6.6 Contura Competitive Strengths & Weaknesses
    7.7 HUGEL
        7.7.1 HUGEL Details
        7.7.2 HUGEL Major Business
        7.7.3 HUGEL Dermal Filler and Botolinum Toxin Product and Services
        7.7.4 HUGEL Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 HUGEL Recent Developments/Updates
        7.7.6 HUGEL Competitive Strengths & Weaknesses
    7.8 Grex Pharma
        7.8.1 Grex Pharma Details
        7.8.2 Grex Pharma Major Business
        7.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Product and Services
        7.8.4 Grex Pharma Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Grex Pharma Recent Developments/Updates
        7.8.6 Grex Pharma Competitive Strengths & Weaknesses
    7.9 Daewoong Pharmaceuticals
        7.9.1 Daewoong Pharmaceuticals Details
        7.9.2 Daewoong Pharmaceuticals Major Business
        7.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product and Services
        7.9.4 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Daewoong Pharmaceuticals Recent Developments/Updates
        7.9.6 Daewoong Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 Medy-Tox
        7.10.1 Medy-Tox Details
        7.10.2 Medy-Tox Major Business
        7.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Product and Services
        7.10.4 Medy-Tox Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Medy-Tox Recent Developments/Updates
        7.10.6 Medy-Tox Competitive Strengths & Weaknesses
    7.11 TEOXANE Laboratories
        7.11.1 TEOXANE Laboratories Details
        7.11.2 TEOXANE Laboratories Major Business
        7.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product and Services
        7.11.4 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 TEOXANE Laboratories Recent Developments/Updates
        7.11.6 TEOXANE Laboratories Competitive Strengths & Weaknesses
    7.12 SciVision Biotech
        7.12.1 SciVision Biotech Details
        7.12.2 SciVision Biotech Major Business
        7.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Product and Services
        7.12.4 SciVision Biotech Dermal Filler and Botolinum Toxin Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 SciVision Biotech Recent Developments/Updates
        7.12.6 SciVision Biotech Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Dermal Filler and Botolinum Toxin Industry Chain
    8.2 Dermal Filler and Botolinum Toxin Upstream Analysis
        8.2.1 Dermal Filler and Botolinum Toxin Core Raw Materials
        8.2.2 Main Manufacturers of Dermal Filler and Botolinum Toxin Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Dermal Filler and Botolinum Toxin Production Mode
    8.6 Dermal Filler and Botolinum Toxin Procurement Model
    8.7 Dermal Filler and Botolinum Toxin Industry Sales Model and Sales Channels
        8.7.1 Dermal Filler and Botolinum Toxin Sales Model
        8.7.2 Dermal Filler and Botolinum Toxin Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Dermal Filler and Botolinum Toxin Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Dermal Filler and Botolinum Toxin Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Dermal Filler and Botolinum Toxin Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Dermal Filler and Botolinum Toxin Production Value Market Share by Region (2018-2023)
    Table 5. World Dermal Filler and Botolinum Toxin Production Value Market Share by Region (2024-2029)
    Table 6. World Dermal Filler and Botolinum Toxin Production by Region (2018-2023) & (K MT)
    Table 7. World Dermal Filler and Botolinum Toxin Production by Region (2024-2029) & (K MT)
    Table 8. World Dermal Filler and Botolinum Toxin Production Market Share by Region (2018-2023)
    Table 9. World Dermal Filler and Botolinum Toxin Production Market Share by Region (2024-2029)
    Table 10. World Dermal Filler and Botolinum Toxin Average Price by Region (2018-2023) & (USD/MT)
    Table 11. World Dermal Filler and Botolinum Toxin Average Price by Region (2024-2029) & (USD/MT)
    Table 12. Dermal Filler and Botolinum Toxin Major Market Trends
    Table 13. World Dermal Filler and Botolinum Toxin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K MT)
    Table 14. World Dermal Filler and Botolinum Toxin Consumption by Region (2018-2023) & (K MT)
    Table 15. World Dermal Filler and Botolinum Toxin Consumption Forecast by Region (2024-2029) & (K MT)
    Table 16. World Dermal Filler and Botolinum Toxin Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Dermal Filler and Botolinum Toxin Producers in 2022
    Table 18. World Dermal Filler and Botolinum Toxin Production by Manufacturer (2018-2023) & (K MT)
    Table 19. Production Market Share of Key Dermal Filler and Botolinum Toxin Producers in 2022
    Table 20. World Dermal Filler and Botolinum Toxin Average Price by Manufacturer (2018-2023) & (USD/MT)
    Table 21. Global Dermal Filler and Botolinum Toxin Company Evaluation Quadrant
    Table 22. World Dermal Filler and Botolinum Toxin Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Dermal Filler and Botolinum Toxin Production Site of Key Manufacturer
    Table 24. Dermal Filler and Botolinum Toxin Market: Company Product Type Footprint
    Table 25. Dermal Filler and Botolinum Toxin Market: Company Product Application Footprint
    Table 26. Dermal Filler and Botolinum Toxin Competitive Factors
    Table 27. Dermal Filler and Botolinum Toxin New Entrant and Capacity Expansion Plans
    Table 28. Dermal Filler and Botolinum Toxin Mergers & Acquisitions Activity
    Table 29. United States VS China Dermal Filler and Botolinum Toxin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Dermal Filler and Botolinum Toxin Production Comparison, (2018 & 2022 & 2029) & (K MT)
    Table 31. United States VS China Dermal Filler and Botolinum Toxin Consumption Comparison, (2018 & 2022 & 2029) & (K MT)
    Table 32. United States Based Dermal Filler and Botolinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Dermal Filler and Botolinum Toxin Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Dermal Filler and Botolinum Toxin Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Dermal Filler and Botolinum Toxin Production (2018-2023) & (K MT)
    Table 36. United States Based Manufacturers Dermal Filler and Botolinum Toxin Production Market Share (2018-2023)
    Table 37. China Based Dermal Filler and Botolinum Toxin Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Dermal Filler and Botolinum Toxin Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Dermal Filler and Botolinum Toxin Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Dermal Filler and Botolinum Toxin Production (2018-2023) & (K MT)
    Table 41. China Based Manufacturers Dermal Filler and Botolinum Toxin Production Market Share (2018-2023)
    Table 42. Rest of World Based Dermal Filler and Botolinum Toxin Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production (2018-2023) & (K MT)
    Table 46. Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production Market Share (2018-2023)
    Table 47. World Dermal Filler and Botolinum Toxin Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Dermal Filler and Botolinum Toxin Production by Type (2018-2023) & (K MT)
    Table 49. World Dermal Filler and Botolinum Toxin Production by Type (2024-2029) & (K MT)
    Table 50. World Dermal Filler and Botolinum Toxin Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Dermal Filler and Botolinum Toxin Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Dermal Filler and Botolinum Toxin Average Price by Type (2018-2023) & (USD/MT)
    Table 53. World Dermal Filler and Botolinum Toxin Average Price by Type (2024-2029) & (USD/MT)
    Table 54. World Dermal Filler and Botolinum Toxin Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Dermal Filler and Botolinum Toxin Production by Application (2018-2023) & (K MT)
    Table 56. World Dermal Filler and Botolinum Toxin Production by Application (2024-2029) & (K MT)
    Table 57. World Dermal Filler and Botolinum Toxin Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Dermal Filler and Botolinum Toxin Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Dermal Filler and Botolinum Toxin Average Price by Application (2018-2023) & (USD/MT)
    Table 60. World Dermal Filler and Botolinum Toxin Average Price by Application (2024-2029) & (USD/MT)
    Table 61. Allergan Basic Information, Manufacturing Base and Competitors
    Table 62. Allergan Major Business
    Table 63. Allergan Dermal Filler and Botolinum Toxin Product and Services
    Table 64. Allergan Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Allergan Recent Developments/Updates
    Table 66. Allergan Competitive Strengths & Weaknesses
    Table 67. Galderma Basic Information, Manufacturing Base and Competitors
    Table 68. Galderma Major Business
    Table 69. Galderma Dermal Filler and Botolinum Toxin Product and Services
    Table 70. Galderma Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Galderma Recent Developments/Updates
    Table 72. Galderma Competitive Strengths & Weaknesses
    Table 73. Merz Pharma GmbH & Co. KGaA Basic Information, Manufacturing Base and Competitors
    Table 74. Merz Pharma GmbH & Co. KGaA Major Business
    Table 75. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product and Services
    Table 76. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Merz Pharma GmbH & Co. KGaA Recent Developments/Updates
    Table 78. Merz Pharma GmbH & Co. KGaA Competitive Strengths & Weaknesses
    Table 79. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 80. Anika Therapeutics Major Business
    Table 81. Anika Therapeutics Dermal Filler and Botolinum Toxin Product and Services
    Table 82. Anika Therapeutics Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Anika Therapeutics Recent Developments/Updates
    Table 84. Anika Therapeutics Competitive Strengths & Weaknesses
    Table 85. Suneva Medical Basic Information, Manufacturing Base and Competitors
    Table 86. Suneva Medical Major Business
    Table 87. Suneva Medical Dermal Filler and Botolinum Toxin Product and Services
    Table 88. Suneva Medical Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Suneva Medical Recent Developments/Updates
    Table 90. Suneva Medical Competitive Strengths & Weaknesses
    Table 91. Contura Basic Information, Manufacturing Base and Competitors
    Table 92. Contura Major Business
    Table 93. Contura Dermal Filler and Botolinum Toxin Product and Services
    Table 94. Contura Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Contura Recent Developments/Updates
    Table 96. Contura Competitive Strengths & Weaknesses
    Table 97. HUGEL Basic Information, Manufacturing Base and Competitors
    Table 98. HUGEL Major Business
    Table 99. HUGEL Dermal Filler and Botolinum Toxin Product and Services
    Table 100. HUGEL Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. HUGEL Recent Developments/Updates
    Table 102. HUGEL Competitive Strengths & Weaknesses
    Table 103. Grex Pharma Basic Information, Manufacturing Base and Competitors
    Table 104. Grex Pharma Major Business
    Table 105. Grex Pharma Dermal Filler and Botolinum Toxin Product and Services
    Table 106. Grex Pharma Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Grex Pharma Recent Developments/Updates
    Table 108. Grex Pharma Competitive Strengths & Weaknesses
    Table 109. Daewoong Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 110. Daewoong Pharmaceuticals Major Business
    Table 111. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product and Services
    Table 112. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Daewoong Pharmaceuticals Recent Developments/Updates
    Table 114. Daewoong Pharmaceuticals Competitive Strengths & Weaknesses
    Table 115. Medy-Tox Basic Information, Manufacturing Base and Competitors
    Table 116. Medy-Tox Major Business
    Table 117. Medy-Tox Dermal Filler and Botolinum Toxin Product and Services
    Table 118. Medy-Tox Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Medy-Tox Recent Developments/Updates
    Table 120. Medy-Tox Competitive Strengths & Weaknesses
    Table 121. TEOXANE Laboratories Basic Information, Manufacturing Base and Competitors
    Table 122. TEOXANE Laboratories Major Business
    Table 123. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product and Services
    Table 124. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. TEOXANE Laboratories Recent Developments/Updates
    Table 126. SciVision Biotech Basic Information, Manufacturing Base and Competitors
    Table 127. SciVision Biotech Major Business
    Table 128. SciVision Biotech Dermal Filler and Botolinum Toxin Product and Services
    Table 129. SciVision Biotech Dermal Filler and Botolinum Toxin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Dermal Filler and Botolinum Toxin Upstream (Raw Materials)
    Table 131. Dermal Filler and Botolinum Toxin Typical Customers
    Table 132. Dermal Filler and Botolinum Toxin Typical Distributors
List of Figure
    Figure 1. Dermal Filler and Botolinum Toxin Picture
    Figure 2. World Dermal Filler and Botolinum Toxin Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Dermal Filler and Botolinum Toxin Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Dermal Filler and Botolinum Toxin Production (2018-2029) & (K MT)
    Figure 5. World Dermal Filler and Botolinum Toxin Average Price (2018-2029) & (USD/MT)
    Figure 6. World Dermal Filler and Botolinum Toxin Production Value Market Share by Region (2018-2029)
    Figure 7. World Dermal Filler and Botolinum Toxin Production Market Share by Region (2018-2029)
    Figure 8. North America Dermal Filler and Botolinum Toxin Production (2018-2029) & (K MT)
    Figure 9. Europe Dermal Filler and Botolinum Toxin Production (2018-2029) & (K MT)
    Figure 10. China Dermal Filler and Botolinum Toxin Production (2018-2029) & (K MT)
    Figure 11. Japan Dermal Filler and Botolinum Toxin Production (2018-2029) & (K MT)
    Figure 12. Dermal Filler and Botolinum Toxin Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 15. World Dermal Filler and Botolinum Toxin Consumption Market Share by Region (2018-2029)
    Figure 16. United States Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 17. China Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 18. Europe Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 19. Japan Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 20. South Korea Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 21. ASEAN Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 22. India Dermal Filler and Botolinum Toxin Consumption (2018-2029) & (K MT)
    Figure 23. Producer Shipments of Dermal Filler and Botolinum Toxin by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Dermal Filler and Botolinum Toxin Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Dermal Filler and Botolinum Toxin Markets in 2022
    Figure 26. United States VS China: Dermal Filler and Botolinum Toxin Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Dermal Filler and Botolinum Toxin Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Dermal Filler and Botolinum Toxin Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Dermal Filler and Botolinum Toxin Production Market Share 2022
    Figure 30. China Based Manufacturers Dermal Filler and Botolinum Toxin Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Dermal Filler and Botolinum Toxin Production Market Share 2022
    Figure 32. World Dermal Filler and Botolinum Toxin Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Dermal Filler and Botolinum Toxin Production Value Market Share by Type in 2022
    Figure 34. Hyaluronic Acid Based Fillers
    Figure 35. Non-Hyaluronic Acid Based Fillers
    Figure 36. Botulinum Toxin
    Figure 37. World Dermal Filler and Botolinum Toxin Production Market Share by Type (2018-2029)
    Figure 38. World Dermal Filler and Botolinum Toxin Production Value Market Share by Type (2018-2029)
    Figure 39. World Dermal Filler and Botolinum Toxin Average Price by Type (2018-2029) & (USD/MT)
    Figure 40. World Dermal Filler and Botolinum Toxin Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Dermal Filler and Botolinum Toxin Production Value Market Share by Application in 2022
    Figure 42. Aesthetic Restoration
    Figure 43. Wrinkle Reduction
    Figure 44. World Dermal Filler and Botolinum Toxin Production Market Share by Application (2018-2029)
    Figure 45. World Dermal Filler and Botolinum Toxin Production Value Market Share by Application (2018-2029)
    Figure 46. World Dermal Filler and Botolinum Toxin Average Price by Application (2018-2029) & (USD/MT)
    Figure 47. Dermal Filler and Botolinum Toxin Industry Chain
    Figure 48. Dermal Filler and Botolinum Toxin Procurement Model
    Figure 49. Dermal Filler and Botolinum Toxin Sales Model
    Figure 50. Dermal Filler and Botolinum Toxin Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech

Related Reports

Global Dermal Filler and Botolinum Toxin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Dermal Filler and Botolinum Toxin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dermal Filler and Botolinum Toxin market size was valued at USD 12400 million in 2023 and is forecast to a readjusted size of USD 29760 million by 2030 with a CAGR of 13.3% during review period.

Global Dermal Filler and Botolinum Toxin Supply, Demand and Key Producers, 2024-2030

Global Dermal Filler and Botolinum Toxin Supply, Demand and Key Producers, 2024-2030

date 28 Feb 2024

date Pharma & Healthcare

The global Dermal Filler and Botolinum Toxin market size is expected to reach $ 29760 million by 2030, rising at a market growth of 13.3% CAGR during the forecast period (2024-2030).

Product Tags

Dermal Filler and Botolinum Toxin

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>